Full-Time
Director – Patient Supply
Posted on 3/13/2024
Pioneering CRISPR base editing genetic medicines
Senior, Expert
Cambridge, MA, USA
Beam Therapeutics is a cutting-edge biopharmaceutical company specializing in CRISPR base editing technology. This innovative approach enables precise, permanent modifications to single bases in DNA and RNA, paving the way for advanced genetic medicines tailored to cure serious diseases. The firm's commitment to precision and potential to offer life-long relief for patients make it an outstanding workplace for professionals passionate about leading transformative healthcare solutions.
Company Stage
IPO
Total Funding
$689M
Headquarters
Cambridge, Massachusetts
Founded
2017